Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Alto Neuroscience (ANRO) Profit After Tax (2023 - 2026)

Alto Neuroscience has reported Profit After Tax over the past 4 years, most recently at -$26.2 million for Q1 2026.

  • Quarterly results put Profit After Tax at -$26.2 million for Q1 2026, down 72.96% from a year ago — trailing twelve months through Mar 2026 was -$74.3 million (down 17.6% YoY), and the annual figure for FY2025 was -$63.2 million, down 2.94%.
  • Profit After Tax reached -$26.2 million in Q1 2026 per ANRO's latest filing, down from -$16.2 million in the prior quarter.
  • Across five years, Profit After Tax topped out at -$7.3 million in Q1 2023 and bottomed at -$26.2 million in Q1 2026.
  • Median Profit After Tax over the past 4 years was -$15.2 million (2025), compared with a mean of -$14.4 million.
  • The largest annual shift saw Profit After Tax crashed 85.04% in 2024 before it grew 15.5% in 2025.
  • Over 4 years, Profit After Tax stood at -$11.2 million in 2023, then plummeted by 35.52% to -$15.2 million in 2024, then dropped by 6.45% to -$16.2 million in 2025, then crashed by 62.14% to -$26.2 million in 2026.
  • Business Quant data shows Profit After Tax for ANRO at -$26.2 million in Q1 2026, -$16.2 million in Q4 2025, and -$14.2 million in Q3 2025.